ZA201000188B - Macrolide solid-state forms - Google Patents

Macrolide solid-state forms

Info

Publication number
ZA201000188B
ZA201000188B ZA201000188A ZA201000188A ZA201000188B ZA 201000188 B ZA201000188 B ZA 201000188B ZA 201000188 A ZA201000188 A ZA 201000188A ZA 201000188 A ZA201000188 A ZA 201000188A ZA 201000188 B ZA201000188 B ZA 201000188B
Authority
ZA
South Africa
Prior art keywords
state forms
macrolide solid
macrolide
solid
forms
Prior art date
Application number
ZA201000188A
Other languages
English (en)
Inventor
Fritz Blatter
Meinrad Brenner
Guixian Hu
Timo Rager
Ralf Warrass
Original Assignee
Intervet Int Bv
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Microbial Chem Res Found filed Critical Intervet Int Bv
Publication of ZA201000188B publication Critical patent/ZA201000188B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epidemiology (AREA)
ZA201000188A 2007-07-26 2010-01-11 Macrolide solid-state forms ZA201000188B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07113244A EP2019112A1 (en) 2007-07-26 2007-07-26 Macrolide solid-state forms

Publications (1)

Publication Number Publication Date
ZA201000188B true ZA201000188B (en) 2010-09-29

Family

ID=39467287

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201000188A ZA201000188B (en) 2007-07-26 2010-01-11 Macrolide solid-state forms

Country Status (13)

Country Link
EP (3) EP2019112A1 (enExample)
JP (7) JP5925989B2 (enExample)
KR (2) KR102508115B1 (enExample)
CN (5) CN103360447B (enExample)
AU (1) AU2008278969B8 (enExample)
BR (1) BRPI0814318B1 (enExample)
CA (1) CA2693801C (enExample)
ES (2) ES2805534T3 (enExample)
HU (1) HUE031449T2 (enExample)
RU (1) RU2476438C2 (enExample)
TW (1) TWI427083B (enExample)
WO (1) WO2009013351A2 (enExample)
ZA (1) ZA201000188B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5323696B2 (ja) 2006-07-28 2013-10-23 インターベツト・インターナシヨナル・ベー・ベー マクロライド合成方法
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
PL2782922T3 (pl) 2011-11-25 2018-07-31 Bayer Intellectual Property Gmbh Przeciwbakteryjne pochodne tylozynowe i sposoby ich wytwarzania
CN102816196A (zh) * 2012-09-10 2012-12-12 河北远征药业有限公司 泰地罗新半抗原、人工抗原及其制备方法
HUE037868T2 (hu) * 2013-05-23 2018-09-28 Bayer Animal Health Gmbh Tilozin-származékok és eljárás elõállításukra
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104774223A (zh) * 2015-03-26 2015-07-15 宁夏泰瑞制药股份有限公司 一种利用泰乐菌素碱生产泰地罗新的方法
CN105254693B (zh) * 2015-11-13 2017-12-22 周金华 一种泰地罗新的合成方法
CN106008629B (zh) * 2016-06-02 2019-11-22 天津大学 泰地罗新1,4-二氧六环溶剂化合物及制备方法
CN106083958B (zh) * 2016-06-02 2019-07-23 天津大学 泰地罗新环己烷溶剂化合物及制备方法
CN106046084B (zh) * 2016-06-02 2019-08-09 天津大学 泰地罗新丙酮溶剂化合物及制备方法
CN109721633A (zh) * 2017-10-31 2019-05-07 齐鲁晟华制药有限公司 一种泰地罗新晶型a及其制备方法
CN112218877B (zh) 2018-08-27 2025-07-25 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
CN111349130A (zh) * 2018-12-21 2020-06-30 齐鲁动物保健品有限公司 一种泰地罗新晶型b及其制备方法
ES3032032T3 (en) 2020-12-03 2025-07-15 Intervet Int Bv Tildipirosin for the treatment of foot rot
CN114213484A (zh) * 2021-12-21 2022-03-22 河北远征药业有限公司 一种泰地罗新1，2-丙二醇溶剂化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761588A (en) * 1969-02-06 1973-09-25 Meiji Seika Kaisha Antibiotics and production thereof
AU561147B2 (en) 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
US4820695A (en) 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
SI8311553A8 (en) * 1983-07-18 1995-06-30 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladynosil-12-0-desosaminyl-4,5-dihydroxy-6- ethyl-3,5,9,11,13,15-hexamethylbicyclo (11.2.1.) hexadeca-1(2)-ene-8-ones
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4920103A (en) 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
DE122011100013I1 (de) * 1999-08-30 2011-09-15 Zaidan Hojin Biseibutsu Makrolid-antibiotika und behandlung von pasteurellosis.
EP3738591A3 (en) * 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
AU2003269473A1 (en) * 2003-08-26 2005-03-10 Biocon Limited A process for the recovery of substantially pure tricyclic macrolide
MX2007006119A (es) * 2005-01-05 2007-07-19 Teva Gyogyszergyar Zartkoruen Tacrolimus amorfo y preparacion de el.
JP5323696B2 (ja) * 2006-07-28 2013-10-23 インターベツト・インターナシヨナル・ベー・ベー マクロライド合成方法
UA98303C2 (ru) * 2006-07-28 2012-05-10 Интервет Интернешонал Б.В. Способ синтеза макролидов
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms

Also Published As

Publication number Publication date
CN103360446B (zh) 2016-04-06
WO2009013351A2 (en) 2009-01-29
CN101778858B (zh) 2013-12-04
JP2010534635A (ja) 2010-11-11
JP5925989B2 (ja) 2016-05-25
EP2019112A1 (en) 2009-01-28
WO2009013351A3 (en) 2009-04-02
BRPI0814318B1 (pt) 2021-04-06
AU2008278969B2 (en) 2011-11-17
ES2805534T3 (es) 2021-02-12
RU2010107057A (ru) 2011-09-10
JP2018104449A (ja) 2018-07-05
CA2693801A1 (en) 2009-01-29
KR20160003899A (ko) 2016-01-11
JP2020172517A (ja) 2020-10-22
EP3170833B1 (en) 2020-05-20
KR20100044864A (ko) 2010-04-30
EP2181117A2 (en) 2010-05-05
CN103467548A (zh) 2013-12-25
EP2181117B1 (en) 2016-11-09
JP2016147858A (ja) 2016-08-18
CN103360445A (zh) 2013-10-23
CN103360447B (zh) 2016-04-06
EP3170833A1 (en) 2017-05-24
ES2608978T3 (es) 2017-04-17
HUE031449T2 (en) 2017-07-28
RU2476438C2 (ru) 2013-02-27
CA2693801C (en) 2018-08-14
KR102508115B1 (ko) 2023-03-08
JP6343624B2 (ja) 2018-06-13
CN101778858A (zh) 2010-07-14
AU2008278969A1 (en) 2009-01-29
TW200918547A (en) 2009-05-01
JP2018109020A (ja) 2018-07-12
JP2014088394A (ja) 2014-05-15
CN103360446A (zh) 2013-10-23
CN103360447A (zh) 2013-10-23
BRPI0814318A2 (pt) 2015-01-06
CN103360445B (zh) 2016-05-18
TWI427083B (zh) 2014-02-21
JP2020172516A (ja) 2020-10-22
AU2008278969B8 (en) 2012-03-15

Similar Documents

Publication Publication Date Title
ZA201000188B (en) Macrolide solid-state forms
DE602008005470D1 (en) Imidazopyridinone
AP2010005314A0 (en) Nanodispersian
GB0710995D0 (en) Combines
GB0710994D0 (en) Combines
GB0711032D0 (en) Combines
GB0717365D0 (en) Imaging
IL200613A0 (en) Erythromycin-based macrolides
GB0723387D0 (en) Improved dehumldifier
GB0711031D0 (en) Combines
EP2134587A4 (en) INTERMEDIATE TRACTION BAR ARRANGEMENT
GB0806180D0 (en) Improved structure
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0622348D0 (en) Retaining means
AU3646P (en) TAS300 Dianella tasmanica
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3642P (en) TAS100 Dianella tasmanica
AU3702P (en) DarwinGold Dianella ensifolia
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3606P (en) Jaywick xTriticosecale
GB0721702D0 (en) Hydrogienic globaltechnology limited
GB0713975D0 (en) No Riveal
GB0714068D0 (en) No riveal
GB0725328D0 (en) Data-handleing means